Table 2 Immune responses against Giardia and control antigens as measured by 3H-thymidine proliferation assay
From: Giardia-specific cellular immune responses in post-giardiasis chronic fatigue syndrome
Exposed | Unexposed | p-values | |||||
|---|---|---|---|---|---|---|---|
Stimulation agent | No PI-fatigue controls (n = 19) | PI-CFS & ICF (n = 19) | Fatigue other cause (n = 9) | Recovered from fatigue (n = 9) | Healthy controls (n = 10) | Exposed n = 56)vs unexposed (n = 10) | No PI-fatigue controls (n= 19) vs PI-CFS/ICF(n = 19) |
Giardia ass A 10 μg/ml | 12.8 (13.0) | 15.3 (19.9) | 20.3 (10.9) | 15.1 (65.0) | 3.5 (6.2) | 0.001 | ns* |
Giardia ass B 10 μg/ml | 12.2 (13.9) | 13.3 (15.3) | 23.3 (13.4) | 15.3 (39.0) | 3.5 (4.7) | <0.001 | ns* |
Tuberculin (PPD)10 μg/ml | 26.3 (34.1) | 34.0 (47.5) | 54.9 (84.5) | 42.5 (23.2) | 27.7 (27.0) | ns | ns* |
LP S Stypi 1 μg/ml | 21.5 (18.6) | 14.4 (13.2) | 38.2 (34.3) | 21.9 (19.5) | 17.7 (10.5) | ns | ns* |
C albicans 10 μg/ml | 7.0 (9.1) | 5.8 (11.9) | 10.0 (32.0) | 14.6 (6.0) | 11.0 (9.4) | ns | ns* |
aCD3aCD28(pos ctr) | 70.6 (35.4) | 51.4 (33.0) | 51.8 (44.1) | 51.8 (63.9) | 60.1 (39.8) | ns | ns* |